Suvera key facts
as of Oct 2026- Developer of a virtual healthcare platform designed to deliver healthcare that keeps people in good health.
- Suvera is valued at approximately $38.5M as of Oct 2026 (last reported valuation).
- It has raised $16.8M; the latest was Accelerator/Incubator in May 2025.
- Notable investors include Ascension, Morningside Group, Calm/Storm Ventures, The NHS Innovation Accelerator, Millennium Technology Value Partners — 11 tracked in total.
- Status: Privately Held (backing).
Suvera's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch Suvera: the Monday email on marks, rounds and moves
Suvera funding rounds
No funding rounds for Suvera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Suvera
11+Suvera valuation
Suvera's last reported valuation was $38.5 million in Feb 2025. No priced round, secondary trade or fund mark has surfaced since.
Suvera investors
11 investors are on record for Suvera, including Ascension, Morningside Group, Calm/Storm Ventures and The NHS Innovation Accelerator.
About Suvera
Developer of a virtual healthcare platform designed to deliver healthcare that keeps people in good health. The company's platform facilitates general practices to virtually manage patients with long-term conditions such as hypertension, diabetes, asthma, chronic obstructive pulmonary disease, depression, and anxiety, enabling patients to reach their health achievements.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Employees
- 65
- Website
- suvera.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.